Primary prevention of allergic sensitisation - How might it work?

Citation
T. Uhlig et al., Primary prevention of allergic sensitisation - How might it work?, BIODRUGS, 12(1), 1999, pp. 13-18
Citations number
59
Categorie Soggetti
Pharmacology
Journal title
BIODRUGS
ISSN journal
11738804 → ACNP
Volume
12
Issue
1
Year of publication
1999
Pages
13 - 18
Database
ISI
SICI code
1173-8804(199907)12:1<13:PPOAS->2.0.ZU;2-0
Abstract
Allergic diseases, particularly allergic asthma, are among the most frequen t disorders seen in paediatric practice and clinic. Epidemiological data as well as recent immunological studies have largely contributed to the ident ification of risk factors eventually leading to the clinical manifestation of allergy. Various strategies of primary prevention are being developed an d most of them include avoidance of identified or presumed risk factors. Another promising field of research investigates pharmacological approaches in the prevention of allergy, and drugs have been identified which interfe re with the pathophysiological pathways. It seems likely that they may play an important role in future primary prevention strategies especially targe ting infants at high risk.